Patients

We are focused on building an innovative pipeline of best-in-class and first-in-class drugs to benefit patients with liver and gastrointestinal diseases. Clinical trials are an important part of helping bring safe and effective medicines to patients.

All product candidates go through a rigorous series of clinical trials, and regulatory agencies, including the U.S. Food and Drug Administration and European Medicines Agency, decide whether to approve medicines based on the results of those trials.

For patients who lack effective treatments, clinical trials are also an opportunity to be a part of testing a new product candidate. By taking part in clinical trials, patients can make an important contribution to ongoing research and better understanding of a disease.

Check back at this website for information about upcoming clinical trials.